| FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
|
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | ||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
EMAGEON INC [ EMAG ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
| 3. Date of Earliest Transaction
(Month/Day/Year)
11/18/2008 |
||||||||||||||||||||||||||
| 4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
|||||||||||||||||||||||||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock, $0.001 Par Value | 11/18/2008 | P | 21,522 | A | $2.4541 | 807,007 | I | By ALSF (Offshore), Ltd. ( 1 ) | ||
| Common Stock, $0.001 Par Value | 11/19/2008 | P | 38,434 | A | $2.4996 | 845,441 | I | By ALSF (Offshore), Ltd. ( 1 ) | ||
| Common Stock, $0.001 Par Value | 11/20/2008 | P | 58,123 | A | $2.486 | 903,564 | I | By ALSF (Offshore), Ltd. ( 1 ) | ||
| Common Stock, $0.001 Par Value | 11/21/2008 | P | 61,164 | A | $2.4898 | 964,728 | I | By ALSF (Offshore), Ltd. ( 1 ) | ||
| Common Stock, $0.001 Par Value | 11/24/2008 | P | 10,000 | A | $2.5125 | 974,728 | I | By ALSF (Offshore), Ltd. ( 1 ) | ||
| Common Stock, $0.001 Par Value | 11/25/2008 | P | 81,460 | A | $2.4821 | 1,056,188 | I | By ALSF (Offshore), Ltd. ( 1 ) | ||
| Common Stock, $0.001 Par Value | 11/18/2008 | P | 17,178 | A | $2.4541 | 788,029 | I | By ALSF, LP ( 2 ) | ||
| Common Stock, $0.001 Par Value | 11/19/2008 | P | 36,463 | A | $2.4996 | 824,492 | I | By ALSF, LP ( 2 ) | ||
| Common Stock, $0.001 Par Value | 11/20/2008 | P | 56,777 | A | $2.486 | 881,269 | I | By ALSF, LP ( 2 ) | ||
| Common Stock, $0.001 Par Value | 11/21/2008 | P | 59,476 | A | $2.4898 | 940,745 | I | By ALSF, LP ( 2 ) | ||
| Common Stock, $0.001 Par Value | 11/25/2008 | P | 78,540 | A | $2.4821 | 1,019,285 | I | By ALSF, LP ( 2 ) | ||
| Common Stock, $0.001 Par Value | 662,924 | I | By ALSF II (Offshore), Ltd. ( 3 ) | |||||||
| Common Stock, $0.001 Par Value | 391,076 | I | By ALSF II (QP), LP ( 4 ) | |||||||
| Common Stock, $0.001 Par Value | 295,566 | I | By ALSF II, LP ( 5 ) | |||||||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
1. Name and Address of Reporting Person*
(Street)
|
||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
| Explanation of Responses: |
| 1. Held by Accipiter Life Sciences Fund (Offshore), Ltd. Accipiter Capital Management, LLC, the investment manager of Accipiter Life Sciences Fund (Offshore), Ltd. and Gabe Hoffman, the managing member of Accipiter Capital Management, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein. |
| 2. Held by Accipiter Life Sciences Fund, LP. Candens Capital, LLC, the general partner of Accipiter Life Sciences Fund, LP and Gabe Hoffman, the managing member of Candens Capital, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein. |
| 3. Held by Accipiter Life Sciences Fund II (Offshore), Ltd. Accipiter Capital Management, LLC, the investment manager of Accipiter Life Sciences Fund II (Offshore), Ltd. and Gabe Hoffman, the managing member of Accipiter Capital Management, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein. |
| 4. Held by Accipiter Life Sciences Fund II (QP), LP. Candens Capital, LLC, the general partner of Accipiter Life Sciences Fund II (QP), LP, and Gabe Hoffman, the managing member of Candens Capital, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein. |
| 5. Held by Accipiter Life Sciences Fund II, LP. Candens Capital, LLC, the general partner of Accipiter Life Sciences Fund II, LP and Gabe Hoffman, the managing member of Candens Capital, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein. |
| By: Accipiter Capital Management, LLC; By: /s/ Gabe Hoffman, Managing Member | 11/25/2008 | |
| By: Accipiter Life Sciences Fund II, LP; By: Candens Capital, LLC, its General Partner; By: /s/ Gabe Hoffman, Managing Member | 11/25/2008 | |
| By: Accipiter Life Sciences Fund II (Offshore), Ltd.; By: Accipiter Capital Management, LLC, its Investment Manager; By: /s/ Gabe Hoffman, Managing Member | 11/25/2008 | |
| By: Accipiter Life Sciences Fund II (QP), LP; By: Candens Capital, LLC, its General Partner; By: /s/ Gabe Hoffman, Managing Member | 11/25/2008 | |
| By: Accipiter Life Sciences Fund, LP; By: Candens Capital, LLC, its General Partner; By: /s/ Gabe Hoffman, Managing Member | 11/25/2008 | |
| By: Accipiter Life Sciences Fund (Offshore), Ltd.; By: Accipiter Capital Management, LLC, its Investment Manager; By: /s/ Gabe Hoffman, Managing Member | 11/25/2008 | |
| By: Candens Capital, LLC; By: /s/ Gabe Hoffman, Managing Member | 11/25/2008 | |
| /s/ Hoffman, Gabe | 11/25/2008 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||